Ireland
--:--IST
Recruiting Not applicable

Laparoscopic Pectopexy With and Without Mesh Use for Pelvic Organ Prolapse.

NCT07306715 · tracked via the Priya Life Science Turkey tracker
Phase
Not applicable
Started
2026-01-29
Last updated
2026-02-02

Condition(s) studied

Genital Prolapse

Investigational drug(s) / intervention(s)

Meshless Laparoscopic PectopexyLaparoscopic Pectopexy with mesh

Meshless Laparoscopic Pectopexy: The vaginal cuff will be fixed to the pectineal ligament with No. 1, non-absorbable Prolene suture.

Laparoscopic Pectopexy with mesh: The vaginal cuff will be fixed to the pectineal ligament with polypropylene mesh.

Study summary

Genital apical prolapse refers to the descent of the vaginal apex, uterus, or cervix, and surgical treatment is required for adequate apical support. Laparoscopic pectopexy is a surgical method developed as an alternative to the gold standard, sacrocolpopexy, in the treatment of genital organ prolapse, especially for obese patients for whom dissection is difficult. The vaginal cuff is attached to the pectineal ligament with polypropylene mesh in the standard technique. The use of mesh is subject to serious restrictions due to complications such as mesh erosion. Surgical methods without using a mesh may be safer treatment options for patients with genital prolapse. This study aimed to compare the results of Laparoscopic Pectopexy surgery with and without the use of mesh material after hysterectomy.

Eligibility

Sex
FEMALE
Min age
40 Years
Max age
80 Years
Healthy volunteers
No
Inclusion Criteria: * Female patients older than 40 years and younger than 80 years old with symptomatic uterine prolapse * Patients who provided written consent for the surgical procedure * Patients who do not wish to preserve their uterus Exclusion Criteria: * Patients who cannot obtain anesthesia approval for laparoscopic surgery * Patients who have a confirmed or suspected pregnancy * Patients who have abnormal uterine/cervical/vaginal bleeding * Patients with biopsy-confirmed endometrial hyperplasia or cervical dysplasia * Patients with pathology-confirmed genital cancer * Patients undergone chemotherapy or radiotherapy for any type of cancer

Primary outcome measure(s)

  • Apical descensus relapse rate — 12 months after surgery
    The ratio of women with stage 2 or greater vaginal cuff prolapse according to the Pelvic Organ Prolapse Quantification (POP-Q) system.

Trial sites (1)

FacilityCityRegionStatus
Kocaeli University, School of Medicine Köseköy Kocaeli Recruiting
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07306715 on ClinicalTrials.gov ↗ ← All trials in Turkey